Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerulonephritis, IGA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01224028
What this trial is testing

Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients

Who this might be right for
IgA Nephropathy
Astellas Pharma Inc 40
Not applicableUnknownNCT05383547
What this trial is testing

Bortezomib for Treating Glomerular Diseases

Who this might be right for
BortezomibGlomerulonephritisMN+3 more
Ruijin Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03373461
What this trial is testing

Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals 112
Not applicableStudy completedNCT02527902
What this trial is testing

Autonomic Nervous System (ANS) and Renal Function in Immunoglobin A (IgA) Nephropathy

Who this might be right for
IGA Glomerulonephritis
Centre Hospitalier Universitaire de Saint Etienne 12
Post-approval studies (Phase 4)Study completedNCT00755859
What this trial is testing

"Steroids and Azathioprine Versus Steroids Alone in IgAN"

Who this might be right for
IGA Nephropathy
A. Manzoni Hospital 206
Testing effectiveness (Phase 2)Looking for participantsNCT06983028
What this trial is testing

Atacicept in Multiple Glomerular Diseases

Who this might be right for
pMNIgANNephrotic Syndrome+2 more
Vera Therapeutics, Inc. 250
Testing effectiveness (Phase 2)Looking for participantsNCT04663204
What this trial is testing

The Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy

Who this might be right for
Immunoglobulin A NephropathyKidney DiseasesGlomerulonephritis, IGA+3 more
University of Leicester 24
Very early researchLooking for participantsNCT06792799
What this trial is testing

Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus ErthematosusMulti-Drug Resistant Nephrotic Syndrome+1 more
The Children's Hospital of Zhejiang University School of Medicine 36
Large-scale testing (Phase 3)UnknownNCT03357653
What this trial is testing

Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1

Who this might be right for
Glomerulonephritis, Immunoglobulin A (IgA)
Ewha Womans University 174
Not applicableStudy completedNCT02526966
What this trial is testing

Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy

Who this might be right for
IgA Nephropathy
Centre Hospitalier Universitaire de Saint Etienne 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06687174
What this trial is testing

Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy (IgAN)
Wuhan Createrna Science and Technology Co., Ltd 72
Not applicableStudy completedNCT01502579
What this trial is testing

An Observational Study of IgA Nephropathy: Pathological Variants and Clinical Data

Who this might be right for
IgA Nephropathy
Guangdong Provincial People's Hospital 603
Testing effectiveness (Phase 2)Ended earlyNCT03841448
What this trial is testing

Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy (IgAN)Berger DiseaseGlomerulonephritis, IgA
Alnylam Pharmaceuticals 31
Early research (Phase 1)Study completedNCT05174221
What this trial is testing

Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy

Who this might be right for
Kidney DiseaseGlomerulonephritis
Takeda 17
Testing effectiveness (Phase 2)Looking for participantsNCT06676579
What this trial is testing

Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy (IgAN)
Mayo Clinic 16
Post-approval studies (Phase 4)UnknownNCT03468972
What this trial is testing

Effect of Immunosuppression in IgA Nephropathy

Who this might be right for
Biopsy-proven IgA Nephropathy
Yonsei University 174
Not applicableTemporarily pausedNCT02471599
What this trial is testing

Effect of Tonsillectomy on Longterm Renal Outcome of IgA Nephropathy

Who this might be right for
IgA Nephropathy
Sun Yat-sen University 100
Testing effectiveness (Phase 2)UnknownNCT03633864
What this trial is testing

Fecal Microbiota Transplantation for Refractory IgA Nephropathy

Who this might be right for
IgA Nephropathy
Air Force Military Medical University, China 30
Post-approval studies (Phase 4)Looking for participantsNCT06676384
What this trial is testing

Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

Who this might be right for
IgA NephropathyRenal Insufficiency, ChronicIgA Vasculitis+1 more
Christian Medical College, Vellore, India 585
Not applicableLooking for participantsNCT07010250
What this trial is testing

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

Who this might be right for
ANCA Associated VasculitisExtramembranous GlomerulopathyNephrotic Syndrome, Minimal Change+4 more
Assistance Publique - Hôpitaux de Paris 146
Next Page